CA2457163A1 - Derp1 and proderp1 allergen derivatives - Google Patents

Derp1 and proderp1 allergen derivatives Download PDF

Info

Publication number
CA2457163A1
CA2457163A1 CA002457163A CA2457163A CA2457163A1 CA 2457163 A1 CA2457163 A1 CA 2457163A1 CA 002457163 A CA002457163 A CA 002457163A CA 2457163 A CA2457163 A CA 2457163A CA 2457163 A1 CA2457163 A1 CA 2457163A1
Authority
CA
Canada
Prior art keywords
ala
ile
asn
tyr
arg
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
CA002457163A
Other languages
English (en)
French (fr)
Inventor
Alex Bollen
Alain Jacquet
Mauro Magi
Remi M. Palmantier
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
GlaxoSmithKline Biologicals SA
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of CA2457163A1 publication Critical patent/CA2457163A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/43504Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from invertebrates
    • C07K14/43513Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from invertebrates from arachnidae
    • C07K14/43531Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from invertebrates from arachnidae from mites
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/08Antiallergic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K2039/51Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/53DNA (RNA) vaccination
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K2039/555Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K2039/57Medicinal preparations containing antigens or antibodies characterised by the type of response, e.g. Th1, Th2

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Insects & Arthropods (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Toxicology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Pulmonology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
CA002457163A 2001-08-17 2002-08-15 Derp1 and proderp1 allergen derivatives Abandoned CA2457163A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB0120150.8 2001-08-17
GBGB0120150.8A GB0120150D0 (en) 2001-08-17 2001-08-17 Novel compounds
PCT/EP2002/009122 WO2003016340A1 (en) 2001-08-17 2002-08-15 Derp1 and proderp1 allergen derivatives

Publications (1)

Publication Number Publication Date
CA2457163A1 true CA2457163A1 (en) 2003-02-27

Family

ID=9920622

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002457163A Abandoned CA2457163A1 (en) 2001-08-17 2002-08-15 Derp1 and proderp1 allergen derivatives

Country Status (6)

Country Link
US (2) US20040234538A1 (enExample)
EP (1) EP1417226A1 (enExample)
JP (1) JP2005502339A (enExample)
CA (1) CA2457163A1 (enExample)
GB (1) GB0120150D0 (enExample)
WO (1) WO2003016340A1 (enExample)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2003300681A1 (en) * 2002-10-02 2004-05-04 Diamyd Medical Ab Formulation of glutarmic acid decarboxylase (gad65) and serum albumin
GB0304424D0 (en) * 2003-02-26 2003-04-02 Glaxosmithkline Biolog Sa Novel compounds
CA2523402A1 (en) * 2003-04-25 2004-11-11 Novozymes A/S Group 1 mite polypeptide variants
WO2006026994A1 (en) * 2004-09-09 2006-03-16 Alk-Abelló A/S Crystal structure of house dust mite allergen der p 1
FR2889592B1 (fr) * 2005-08-03 2008-09-12 Inst Nat Agronomique Paris Gri Procede pour tester l'aptitude d'une composition a provoquer une reaction allergique croisee avec un allergene derive de l'arachide
EP1835031A1 (en) * 2006-03-14 2007-09-19 Paul-Ehrlich-Institut Bundesamt für Sera und Impfstoffe Use of a recombinant modified vaccinia virus Ankara (MVA) for the treatment of type I hypersensitivity in a living animal including humans
WO2008154350A2 (en) * 2007-06-08 2008-12-18 Alba Therapeutics Corporation Use of tight junction agonists to suppress immune responses
NL2014882B1 (en) 2015-05-29 2017-01-31 Citeq B V Allergy-specific immunotherapy compositions for use in the treatment of house-dust mite allergy.
GB201806819D0 (en) * 2018-04-26 2018-06-13 Univ Gent Compositions for active immunotherapy

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5433948A (en) * 1990-02-13 1995-07-18 Thomas; Wayne R. Cloning and sequencing of allergens of dermatophagoides (house dust mite)
US6849427B1 (en) * 1993-03-12 2005-02-01 Immulogic Pharmaceutical Corp. Nucleic acids encoding a house dust mite allergen, Der p VII, and uses therefor
EP1043032A3 (en) * 1994-07-29 2000-11-15 Kenneth Houlbrook Use of moisture and heat for de-naturing house dust mite (HDM) allergen
US5670356A (en) * 1994-12-12 1997-09-23 Promega Corporation Modified luciferase
US5762943A (en) * 1996-05-14 1998-06-09 Ribi Immunochem Research, Inc. Methods of treating type I hypersensitivity using monophosphoryl lipid A
GB9724531D0 (en) * 1997-11-19 1998-01-21 Smithkline Biolog Novel compounds
US6455686B1 (en) * 1998-04-17 2002-09-24 Heska Corporation Dermatophagoides nucleic acid molecules, proteins and uses thereof
WO2001029078A2 (en) * 1999-10-15 2001-04-26 Heska Corporation Method for production and use of mite group 1 proteins
GB0014288D0 (en) * 2000-06-10 2000-08-02 Smithkline Beecham Biolog Vaccine

Also Published As

Publication number Publication date
JP2005502339A (ja) 2005-01-27
GB0120150D0 (en) 2001-10-10
WO2003016340A1 (en) 2003-02-27
US20040234538A1 (en) 2004-11-25
EP1417226A1 (en) 2004-05-12
US20070122423A1 (en) 2007-05-31

Similar Documents

Publication Publication Date Title
US20060233839A1 (en) Novel compounds
US20070122423A1 (en) Derp1 and proderp1 allergen derivatives
CA2487831A1 (en) Immunogenic compositions
US7173117B2 (en) Codon optimised recombinant Dermaphagoides allergens
US7348009B1 (en) Recombinant allergen with reduced enzymatic activity
US20080063667A1 (en) ProDer P 1 Expressed in a Prokaryotic Cell
EP1317483B1 (en) Variants of allergenic proteins of the group 2 of dermatophagoides
RU2285042C2 (ru) Новые мутантные аллергены
CA2843804C (en) Hypoallergenic variants of mal d 1, the major allergen from malus domestica
CA2495825A1 (en) Variants of the major allergen phl p 1 from timothy grass
CA2558660A1 (en) Fusion proteins comprising modified allergens of the ns-ltps family, use thereof and pharmaceutical compositions comprising the same
JPH0940583A (ja) 組換えDer f IIIアレルゲン及びその製造法
CN1095106A (zh) 疫苗

Legal Events

Date Code Title Description
EEER Examination request
FZDE Discontinued